指南与共识鼻科

2021国际过敏与鼻科学共识声明:鼻窦炎

International consensus statement on allergy and rhinology: rhinosinusitis 2021.
指南 / 共识 · Int Forum Allergy Rhinol · 2021-01-01

ICAR-RS-2021在首版5年后更新,涵盖超过180个主题,包括40余个新主题和140个原主题的更新。本执行摘要汇总了最高级别结构化推荐,涉及22个药物治疗和4个手术治疗主题,并提供基于证据的管理算法。

要点

  • ICAR-RS-2021涵盖超过180个主题,包括40余个新主题和140个原主题更新。
  • 执行摘要汇总了22个药物治疗和4个手术治疗主题的A/B级推荐。
  • 提供基于证据的鼻窦炎综合管理算法。

核心结论

  • ICAR-RS-2021执行摘要汇编了常见鼻窦炎药物和手术治疗基于证据的推荐。

研究设计与样本

  • ICAR-RS-2021由国际共识制定,包含超过180个主题,形式为基于证据的综述与推荐(EBRR)、基于证据的综述和文献综述。

主要发现

  • ICAR-RS-2021涵盖22个药物治疗主题和4个手术治疗主题,均为A/B级推荐,并在执行摘要中呈现。
  • 提供了基于证据的综合管理算法。

关键数值与推荐

  • 22个药物治疗主题为A/B级推荐;4个手术治疗主题为A/B级推荐。

临床怎么用

  • 临床可参考执行摘要中的A/B级推荐和综合管理算法进行鼻窦炎的药物和手术治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: I. EXECUTIVE SUMMARY: BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document. METHODS: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. RESULTS: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided. CONCLUSION: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021. PMID: 33236525. doi:10.1002/alr.22741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。